Literature DB >> 141802

Chronic oral administration of 1-nitrosopiperazine at high doses to MRC rats.

L A Love, W Lijinsky, L K Keefer, H Garcia.   

Abstract

1-Nitrosopiperazine was fed to two groups of rats as drinking water solutions containing 400 mg/liter (3.5 millimolar) and 800 mg/liter (7.0 millimolar), respectively. The treatment was 20 ml per rat per day, 5 days per week for life. In both groups many animals died with olfactory tumors (mostly esthesioneuroblastomas), the first at 36 weeks in the higher dose group, the first at 64 weeks in the lower dose group. There was also a small number of liver tumors in both groups. None of these tumors was seen in the untreated controls. The similarity of this tumor distribution to that produced by 1,4-dinitrosopiperazine suggests that the observed carcinogenicity of 1-nitrosopiperazine may be entirely due to its disproportionation in the acidic medium of the rat stomach. Chemical data supporting this interpretation are presented.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 141802     DOI: 10.1007/bf02571691

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN: 0084-5353


  6 in total

1.  Mutagenicity of N-nitrosopiperazines for Salmonella typhimurium in the host-mediated assay.

Authors:  E Zeiger; M S Legator; W Lijinsky
Journal:  Cancer Res       Date:  1972-07       Impact factor: 12.701

2.  [Organotropic carcinogenic effects of 65 various N-nitroso- compounds on BD rats].

Authors:  H Druckrey; R Preussmann; S Ivankovic; D Schmähl
Journal:  Z Krebsforsch       Date:  1967

3.  Tumorigenicity of five cyclic nitrosamines in MRC rats.

Authors:  H Garcia; W Lijinsky
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1972

4.  Carcinogenicity of nitrosothiomorpholine and 1-nitrosopiperazine in rats.

Authors:  H Garcia; L Keefer; W Lijinsky; C E Wenyon
Journal:  Z Krebsforsch       Date:  1970

5.  Dose-response studies with concurrent administration of piperazine and sodium nitrite to strain A mice.

Authors:  M Greenblatt; S S Mirvish
Journal:  J Natl Cancer Inst       Date:  1973-01       Impact factor: 13.506

6.  Mutagenicity of cyclic nitrosamines in Escherichia coli following activation with rat liver microsomes.

Authors:  R K Elespuru; W Lijinsky
Journal:  Cancer Res       Date:  1976-11       Impact factor: 12.701

  6 in total
  5 in total

1.  Excretion of N-mononitrosopiperazine in urine in workers manufacturing piperazine.

Authors:  T Bellander; B G Osterdahl; L Hagmar; S Skerfving
Journal:  Int Arch Occup Environ Health       Date:  1988       Impact factor: 3.015

Review 2.  Structure-activity relations in carcinogenesis by N-nitroso compounds.

Authors:  W Lijinsky
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Proceedings of the 2011 National Toxicology Program Satellite Symposium.

Authors:  Gary Boorman; Torrie A Crabbs; Holly Kolenda-Roberts; Ken Latimer; Andrew D Miller; Kathleen B Muravnick; Abraham Nyska; Ricardo Ochoa; Ingrid D Pardo; Yuval Ramot; Deepa B Rao; JoAnn Schuh; Andrew Suttie; Greg S Travlos; Jerrold M Ward; Jeffrey C Wolf; Susan A Elmore
Journal:  Toxicol Pathol       Date:  2011-11-16       Impact factor: 1.902

4.  Transformation of the antibacterial agent norfloxacin by environmental mycobacteria.

Authors:  Michael D Adjei; Thomas M Heinze; Joanna Deck; James P Freeman; Anna J Williams; John B Sutherland
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

5.  Practical and Science-Based Strategy for Establishing Acceptable Intakes for Drug Product N-Nitrosamine Impurities.

Authors:  Krista L Dobo; Michelle O Kenyon; Olivier Dirat; Maria Engel; Andrew Fleetwood; Matthew Martin; Susan Mattano; Alyssa Musso; James Christopher McWilliams; Alexandros Papanikolaou; Patricia Parris; Jessica Whritenour; Shu Yu; Amit S Kalgutkar
Journal:  Chem Res Toxicol       Date:  2022-02-25       Impact factor: 3.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.